Pharming Technologies B.V.

Works in Cardiovascular · Dermatology · Genetic & rare · Hematology · Immunology · Metabolic & endocrine · Musculoskeletal · Neurology

Pharming Technologies B.V. is a clinical trial sponsor. It has 5 active clinical trials with 363 planned participants, across 8 therapeutic areas. Since 2021 it has completed 6 trials and stopped 2 early.

Trial track record · since 2021

5Active trials363 planned participants
6Completed3 with results posted
2Stopped early25% of finished trials

Pipeline · 5 active trials

StageTrialStatus

Questions about Pharming Technologies B.V

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-19.

Approve Suite is not affiliated with Pharming Technologies B.V..

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.